• Press Release

Charles Shapiro, MD, Named Co-Director of the Dubin Breast Center

Renown breast cancer researcher joins Mount Sinai’s Tisch Cancer Institute

  • New York, NY
  • (October 30, 2014)

Charles Shapiro, MD, joins Mount Sinai as the Co-Director of the Dubin Breast Center, Director of Translational Breast Cancer Research for the Mount Sinai Health System, and Director of Survivorship Programs at The Tisch Cancer Institute at Mount Sinai.

In his new role, Dr. Shapiro will initiate clinical trials for breast cancer patients, and will work with faculty and staff to create integrative programs that seek to improve the quality of life for breast cancer survivors.

“As a nationally recognized leader in breast medical oncology and research, Dr. Shapiro will help pave the way for the Mount Sinai Health System's innovation in breast cancer treatment and care,” said Elisa Port, MD, Chief of Breast Surgery and Co-Director of the Dubin Breast Center at The Tisch Cancer Institute at Mount Sinai.

Dr. Shapiro comes to Mount Sinai from Ohio State University Comprehensive Cancer Center, where he was Section Chief of Breast Cancer, Breast Research Program Leader, and Director of Breast Medical Oncology.

“We are pleased to welcome Dr. Shapiro to our dynamic research team at The Tisch Cancer Institute at Mount Sinai,” said William Oh, MD, Chief, Division of Hematology and Oncology, Professor of Medicine and Urology and Ezra M. Greenspan, MD Professor in Clinical Cancer Therapeutics at Icahn School of Medicine at Mount Sinai, and Associate Director of Clinical Research, The Tisch Cancer Institute at Mount Sinai.

His research focus is the impact of adjuvant chemotherapy on bone loss in premenopausal women; profiling of triple negative breast cancers to define subsets that have better or worse prognosis; and preclinical evaluations of novel drugs. He currently serves as liaison to Investigational Drug Steering Committee of the National Cancer Institute and is also the Chairman of the American Society of Clinical Oncology's Survivorship Committee. His research has been supported by grants from the National Cancer Institute. He has published over 180 original research papers, reviews and editorials.

In joining Mount Sinai, Dr. Shapiro said, “By integrating clinical, translational and basic scientific researchers into collaborative teams, we will hasten the discovery of new knowledge to create novel approaches to treat and prevent breast cancer.” As the Director of Survivorship Programs, Dr. Shapiro will also help to build and expand the existing survival programs and resources that Mount Sinai offers breast cancer patients.

Dr. Shapiro received his medical degree at SUNY Buffalo, and completed an internship and residency at Temple University Hospital as well as a fellowship at Dana-Farber Cancer Institute and Harvard Medical School.

About the Dubin Breast Center of The Tisch Cancer Institute
The Dubin Breast Center provides a multidisciplinary, comprehensive approach to breast cancer screening, treatment and survivorship. The 15,000-square-foot facility houses a full range of services, including cancer screening and biopsies, cancer treatment including surgery, chemotherapy and radiation, wellness, patient and family support services, education, genetic counseling and testing, onco-fertility services, access to clinical trials, and survivorship support. Patients receive highly personalized, multidisciplinary care in a calming, private, and supportive setting. The Dubin Breast Center offers state-of-the-art diagnostics, including 3-D mammography, and minimally invasive diagnostic procedures.

About the Mount Sinai Health System

The Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient services—from community-based facilities to tertiary and quaternary care.

The System includes approximately 7,100 primary and specialty care physicians; 12 joint-venture ambulatory surgery centers; more than 140 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. Physicians are affiliated with the renowned Icahn School of Medicine at Mount Sinai, which is ranked among the highest in the nation in National Institutes of Health funding per investigator. The Mount Sinai Hospital is in the "Honor Roll" of best hospitals in America, ranked No. 15 nationally in the 2016-2017 "Best Hospitals" issue of U.S. News & World Report. The Mount Sinai Hospital is also ranked as one of the nation's top 20 hospitals in Geriatrics, Gastroenterology/GI Surgery, Cardiology/Heart Surgery, Diabetes/Endocrinology, Nephrology, Neurology/Neurosurgery, and Ear, Nose & Throat, and is in the top 50 in four other specialties. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 10 nationally for Ophthalmology, while Mount Sinai Beth Israel, Mount Sinai St. Luke's, and Mount Sinai West are ranked regionally. Mount Sinai's Kravis Children's Hospital is ranked in seven out of ten pediatric specialties by U.S. News & World Report in "Best Children's Hospitals."

For more information, visit http://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.